Dados B3 › AMBP3 × EQTL3
AMBP3 × EQTL3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | AMBP3 | EQTL3 | year |
|---|---|---|---|
| ROE | -17.1% | 11.9% | 2024 |
| ROIC | 10.7%! | 12.6% | 2024 |
| ROA | -1.3% | 3.4% | 2024 |
| Gross margin | 19.6% | 28.8% | 2024 |
| EBIT margin | 18.3% | 19.0% | 2024 |
| Net margin | -2.7% | 8.3% | 2024 |
| Net debt/EBITDA | 2.76x | 3.76x | 2024 |
| Current ratio | 2.91x | 1.46x | 2024 |
| Revenue growth (1y) | 31.6% | 10.7% | 2024 |
| Revenue growth (5y CAGR) | 67.6% | 19.3% | 2024 |
| Piotroski F-Score | 5/9 | 4/9 | 2024 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | AMBP3 | EQTL3 | year |
|---|---|---|---|
| P/E | -1.62x | 32.35x | 2024 × 2025 |
| P/B | 0.29x | 2.11x | 2024 × 2025 |
| EV/EBITDA | 3.02x | 8.72x | 2024 × 2025 |
| FCF yield | 190.4% | -7.6% | 2024 × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:03 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:03 UTC. If this does not match /saude, you are reading a cached copy.